Seeking Alpha

United Therapeutics Corp. (UTHR)

()

News & PR
Market Currents

Buzz
Twitter: UTHR

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Determining Potential in Health Care Stocks

Oct 30 • J. Royden Ward • 4 Comments
Biotech: Q3 Market Update

Oct 16 • R. Scott Raynovich • 1 Comment
Best Performing Mid and Small Cap Stocks Since 10/9/07 Peak

Oct 9 • Bespoke Investment Group • 1 Comment
Tuesday Options Recap

Oct 6 • Frederic Ruffy • Comment!
United Therapeutics: Gold Star Performance as Second FDA Approval Confirmed

Aug 2 • EP Vantage • Comment!
FDA Calendar Updates: United Therapeutics, Roche

Jul 30 • Mike Havrilla • Comment!
FDA Calendar: 2H09 Binary Event Trades

Jul 27 • Mike Havrilla • 3 Comments
FDA Calendar: 18 Hot Summer Trades

Jun 16 • Mike Havrilla • 4 Comments
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly

May 27 • Mark Cifra • 4 Comments
FDA, Clinical Trial Updates: MAP Pharma, Cytokinetics, Hemispherx Post Big Gains

May 27 • Mike Havrilla • 1 Comment
Tuesday's Options Recap

May 26 • Frederic Ruffy • 2 Comments
FDA, Clinical Trial Updates: Watson Pharma, United Therapeutics, Auxilium, Dendreon

Apr 29 • Mike Havrilla • 1 Comment
FDA and Clinical Trial Updates: United Therapeutics Faces Delays

Mar 18 • Mike Havrilla • 1 Comment
Where Might Genentech Investors Redeploy $47B?

Mar 16 • Michael Becker • 2 Comments
Biopharma: Instead of M&A, Think P&A

Mar 4 • Mike Huckman • 2 Comments
Trading the Trials and FDA Decision Calendar

Jan 26 • Mike Havrilla • 1 Comment
SAC Capital Portfolio Update: 37 13G Filings

Jan 15 • Market Folly • Comment!
5 Potential Buyout Targets in Biotech - Barron's

Aug 17, 2008 • SA Editor Rachael Granby • 9 Comments
A Biotech Bloom in July

Jul 28, 2008 • Option Dragon • 10 Comments
Pfizer Should Buy Amgen or Wyeth - Credit Suisse

Mar 9, 2008 • Mike Huckman • 1 Comment
Loeb's Third Point Issues Latest 13F: Summary of Holdings

Aug 16, 2007 • Lon Juricic • Comment!
Companies With The Most Analyst Attention & Affection

Jun 5, 2007 • Bespoke Investment Group • 3 Comments
Biotech Day In Review: Sanofi-Aventis Lands Cancer Vaccine For $680 Million

Mar 29, 2007 • Centient Biotech Investor • Comment!

United Therapeutics Corp. (UTHR)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers